drugset / Trial / NCT02336607

The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.

NCT02336607

Completed 529 enrolled AstraZeneca
RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to evaluate the effects on blood pressure control, pulse wave velocity, as well as safety and tolerability of felodipine single or combine with other drugs in Chinese Hypertension patients.

Timeline

Start
2005-12
Primary completion
2006-06
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Felodipine Small molecule 5 mg Oral
Subject Felodipine Small molecule 10 mg Oral
Comparator Hydrochlorothiazide Unknown 12.5 mg Oral
Comparator Hydrochlorothiazide Unknown 25 mg Oral
Comparator LISINOPRIL ANHYDROUS Small molecule 10 mg Oral
Comparator LISINOPRIL ANHYDROUS Small molecule 20 mg Oral
Comparator Metoprolol Other / unclassified 47.5 mg Oral
Comparator Metoprolol Other / unclassified 95 mg Oral

Indications